Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report)’s stock price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $1.05 and traded as low as $0.85. Predictive Oncology shares last traded at $0.89, with a volume of 34,725 shares changing hands.
Predictive Oncology Stock Up 2.8 %
The business’s 50 day moving average price is $1.24 and its 200-day moving average price is $1.05. The company has a market cap of $7.97 million, a PE ratio of -0.29 and a beta of 1.11.
Predictive Oncology Company Profile
Predictive Oncology Inc operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.
Further Reading
- Five stocks we like better than Predictive Oncology
- How to Use High Beta Stocks to Maximize Your Investing Profits
- How to Invest in Micro-Cap Stocks Like a Pro
- Growth Stocks: What They Are, What They Are Not
- Investors Sell Microsoft Stock on OpenAI News—Time to Buy?
- What does consumer price index measure?
- Take-Two Interactive: A Defensive Play Set to Explode
Receive News & Ratings for Predictive Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Predictive Oncology and related companies with MarketBeat.com's FREE daily email newsletter.
